Clinical trials
Active, not recruiting Stomach Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
162 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 10 |
| 2020 | 24 |
| 2021 | 21 |
| 2022 | 19 |
| 2023 | 11 |
| 2024 | 26 |
| 2025 | 15 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 162 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| National Cancer Institute (NCI) | 7 |
| Astellas Pharma Global Development, Inc. | 4 |
| Fudan University | 4 |
| Dong Peng | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National Cancer Center, Korea | 3 |
| Seoul National University Bundang Hospital | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| The Netherlands Cancer Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 162 |
| Colorectal Neoplasms | 33 |
| Esophageal Neoplasms | 32 |
| Ovarian Neoplasms | 31 |
| Pancreatic Neoplasms | 30 |
| Carcinoma, Non-Small-Cell Lung | 27 |
| Breast Neoplasms | 18 |
| Melanoma | 16 |
| Endometrial Neoplasms | 15 |
| Carcinoma, Renal Cell | 14 |
Trials
Showing 76 to 100 of 162. Each trial links to its page on Pharma Observatory.
62 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.